title: Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis.
authors.forename: Etienne
authors.initials: E
authors.lastname: Ghrénassia
authors.forename: Arsène
authors.initials: A
authors.lastname: Mékinian
authors.forename: Samir
authors.initials: S
authors.lastname: Rouaghe
authors.forename: Nathalie
authors.initials: N
authors.lastname: Ganne
authors.forename: Olivier
authors.initials: O
authors.lastname: Fain
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D057915:Drug Substitution; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology; D006515:Hepatitis B virus / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D000069283:Rituximab; D016896:Treatment Outcome; D019562:Viral Load / Q000187:drug effects; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000998:Antiviral Agents; D000069283:Rituximab; C413685:entecavir; D006147:Guanine